Toronto Dominion Bank’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-80
| Closed | -$3.27K | – | 1550 |
|
|
2024
Q3 | $3.27K | Sell |
80
-11
| -12% | -$450 | ﹤0.01% | 1097 |
|
|
2024
Q2 | $3.5K | Hold |
91
| – | – | ﹤0.01% | 1204 |
|
|
2024
Q1 | $3.9K | Sell |
91
-80
| -47% | -$3.3K | ﹤0.01% | 1180 |
|
|
2023
Q4 | $6.34K | Buy |
171
+80
| +88% | +$2.87K | ﹤0.01% | 1278 |
|
|
2023
Q3 | $3.3K | Buy |
91
+11
| +14% | +$390 | ﹤0.01% | 1344 |
|
|
2023
Q2 | $3K | Hold |
80
| – | – | ﹤0.01% | 1346 |
|
|
2023
Q1 | $3K | Hold |
80
| – | – | ﹤0.01% | 1339 |
|
|
2022
Q4 | $3K | Hold |
80
| – | – | ﹤0.01% | 1432 |
|
|
2022
Q3 | $2K | Hold |
80
| – | – | ﹤0.01% | 1495 |
|
|
2022
Q2 | $4K | Buy |
+80
| New | +$4.42K | ﹤0.01% | 1217 |
|
|
2020
Q1 | – | Sell |
-560
| Closed | -$33K | – | 1333 |
|
|
2019
Q4 | $33K | Sell |
560
-3,280
| -85% | -$182K | ﹤0.01% | 1177 |
|
|
2019
Q3 | $205K | Buy |
+3,840
| New | +$198K | ﹤0.01% | 1112 |
|
|
2019
Q2 | – | Sell |
-3,360
| Closed | -$175K | – | 1577 |
|
|
2019
Q1 | $175K | Sell |
3,360
-320
| -9% | -$16K | ﹤0.01% | 1182 |
|
|
2018
Q4 | $176K | Hold |
3,680
| – | – | ﹤0.01% | 1114 |
|
|
2018
Q3 | $185K | Hold |
3,680
| – | – | ﹤0.01% | 1071 |
|
|
2018
Q2 | $186K | Buy |
3,680
+1,160
| +46% | +$58.4K | ﹤0.01% | 1138 |
|
|
2018
Q1 | $123K | Buy |
2,520
+1,440
| +133% | +$67.1K | ﹤0.01% | 1095 |
|
|
2017
Q4 | $48K | Sell |
1,080
-5,680
| -84% | -$262K | ﹤0.01% | 1109 |
|
|
2017
Q3 | $344K | Sell |
6,760
-3,200
| -32% | -$162K | ﹤0.01% | 831 |
|
|
2017
Q2 | $538K | Hold |
9,960
| – | – | ﹤0.01% | 764 |
|
|
2017
Q1 | $526K | Sell |
9,960
-2,431
| -20% | -$123K | ﹤0.01% | 766 |
|
|
2016
Q4 | $597K | Sell |
12,391
-440
| -3% | -$21.7K | ﹤0.01% | 729 |
|
|
2016
Q3 | $693K | Hold |
12,831
| – | – | ﹤0.01% | 513 |
|
|
2016
Q2 | $699K | Sell |
12,831
-80
| -0.6% | -$4.21K | ﹤0.01% | 388 |
|
|
2016
Q1 | $652K | Sell |
12,911
-417
| -3% | -$20.8K | ﹤0.01% | 335 |
|
|
2015
Q4 | $675K | Sell |
13,328
-868
| -6% | -$44.2K | ﹤0.01% | 438 |
|
|
2015
Q3 | $685K | Hold |
14,196
| – | – | ﹤0.01% | 417 |
|
|
2015
Q2 | $739K | Sell |
14,196
-200
| -1% | -$11.3K | ﹤0.01% | 444 |
|
|
2015
Q1 | $830K | Buy |
14,396
+25
| +0.2% | +$1.43K | ﹤0.01% | 411 |
|
|
2014
Q4 | $767K | Buy |
14,371
+680
| +5% | +$38K | ﹤0.01% | 472 |
|
|
2014
Q3 | $1M | Sell |
13,691
-1,860
| -12% | -$114K | ﹤0.01% | 357 |
|
|
2014
Q2 | $1.04M | Buy |
15,551
+80
| +0.5% | +$5.42K | ﹤0.01% | 374 |
|
|
2014
Q1 | $1.07M | Buy |
15,471
+1,475
| +11% | +$99.7K | ﹤0.01% | 350 |
|
|
2013
Q4 | $933K | Buy |
13,996
+496
| +4% | +$32.2K | ﹤0.01% | 355 |
|
|
2013
Q3 | $845K | Buy |
13,500
+7,352
| +120% | +$473K | ﹤0.01% | 325 |
|
|
2013
Q2 | $385K | Buy |
+6,148
| New | +$390K | ﹤0.01% | 428 |
|
Other funds holding GSK
JEST
Toronto Dominion Bank's GSK Position: Q4 2024 in Review
Toronto Dominion Bank sold out of GSK (GSK) in Q4 2024, closing a stake of 80 shares — an estimated $3.27K sold.
Toronto Dominion Bank first reported a position in GSK in Q2 2013 and held it in 36 quarters. The position peaked at $1.07M in Q1 2014. 848 funds tracked by Wall St. Rank hold GSK as of Q4 2024.
- Toronto Dominion Bank reported no remaining GSK position as of Q4 2024 after selling out during the quarter.
- Toronto Dominion Bank sold 80 GSK shares in Q4 2024, an estimated $3.27K.
- Toronto Dominion Bank first reported a position in GSK in Q2 2013 and held it in 36 quarters.
- Toronto Dominion Bank's GSK position peaked at $1.07M in Q1 2014.
- 848 funds tracked by Wall St. Rank held GSK as of Q4 2024.
Based on Toronto Dominion Bank's 13F filing for Q4 2024, filed 14 Feb 2025.